{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:17:14Z","timestamp":1790018234236,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,10]],"date-time":"2007-07-10T00:00:00Z","timestamp":1184025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s00213-007-0861-5","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T02:56:42Z","timestamp":1184641002000},"page":"505-515","source":"Crossref","is-referenced-by-count":150,"title":["Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users"],"prefix":"10.1007","volume":"194","author":[{"given":"Marilyn A.","family":"Huestis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Heishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzie L.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Le Fur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,10]]},"reference":[{"key":"861_CR1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/sj.npp.1300454","volume":"29","author":"K Anggadiredja","year":"2004","unstructured":"Anggadiredja K, Nakamichi M, Hiranita T, Tanaka H, Shoyama Y, Watanabe S, Yamamoto T (2004) Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29:1470\u20131478","journal-title":"Neuropsychopharmacology"},{"key":"861_CR2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","volume":"132","author":"M Arnone","year":"1997","unstructured":"Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, LeFur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132:104\u2013106","journal-title":"Psychopharmacology"},{"key":"861_CR3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","volume":"63","author":"M Bensaid","year":"2003","unstructured":"Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells. Mol Pharmacol 63:908\u2013914","journal-title":"Mol Pharmacol"},{"key":"861_CR4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejphar.2004.05.005","volume":"494","author":"MA Carai","year":"2004","unstructured":"Carai MA, Colombo G, Gessa GL (2004) Rapid tolerance to the intestinal prokinetic effect of cannabinoid CB1 receptor antagonist, SR 141716 (rimonabant). Eur J Pharmacol 494:221\u2013224","journal-title":"Eur J Pharmacol"},{"key":"861_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0376-8716(85)90002-X","volume":"15","author":"LD Chait","year":"1985","unstructured":"Chait LD, Fischman MW, Schuster CR (1985) Hangover effects the morning after marijuana smoking. Drug Alcohol Depend 15:229\u2013238","journal-title":"Drug Alcohol Depend"},{"key":"861_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","volume":"13","author":"F Chaperon","year":"1999","unstructured":"Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243\u2013281","journal-title":"Crit Rev Neurobiol"},{"key":"861_CR7","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1460-9568.2005.04056.x","volume":"21","author":"A Cippitelli","year":"2005","unstructured":"Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermudez-Silva FJ, Navarro M, Ciccocioppo R, de Fonseca FR (2005) Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21:2243\u20132251","journal-title":"Eur J Neurosci"},{"key":"861_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejheart.2004.04.014","volume":"6","author":"JG Cleland","year":"2004","unstructured":"Cleland JG, Ghosh J, Freemantle N, Kaye GC, Nasir M, Clark AL, Coletta AP (2004) Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 6:501\u2013508","journal-title":"Eur J Heart Fail"},{"key":"861_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","volume":"13","author":"C Cohen","year":"2002","unstructured":"Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P (2002) SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451\u2013463","journal-title":"Behav Pharmacol"},{"key":"861_CR10","first-page":"586","volume":"277","author":"DR Compton","year":"1996","unstructured":"Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta-9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586\u2013594","journal-title":"J Pharmacol Exp Ther"},{"key":"861_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","volume":"40","author":"FR Fonseca de","year":"2004","unstructured":"de Fonseca FR, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M (2004) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40:2\u201314","journal-title":"Alcohol Alcohol"},{"key":"861_CR12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","volume":"7","author":"TJ Vries De","year":"2001","unstructured":"De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJMJ, Schoffelmeer ANM (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7:1151\u20131154","journal-title":"Nat Med"},{"key":"861_CR13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-5793(95)00746-V","volume":"369","author":"JM Derocq","year":"1995","unstructured":"Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P (1995) Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 369:177\u2013182","journal-title":"FEBS Lett"},{"key":"861_CR14","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","volume":"353","author":"JP Despres","year":"2005","unstructured":"Despres JP, Golay A, Sjostrom L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353:2121\u20132134","journal-title":"N Engl J Med"},{"key":"861_CR15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V DiMarzo","year":"2001","unstructured":"DiMarzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jaral Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822\u2013825","journal-title":"Nature"},{"key":"861_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0033291700054283","volume":"3","author":"MF Folstein","year":"1973","unstructured":"Folstein MF, Luria R (1973) Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol Med 3:479\u2013486","journal-title":"Psychol Med"},{"key":"861_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(01)00953-0","volume":"419","author":"E Fride","year":"2001","unstructured":"Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R (2001) Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol 419:207\u2013214","journal-title":"Eur J Pharmacol"},{"key":"861_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"252","author":"S Galiegue","year":"1995","unstructured":"Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 252:54\u201361","journal-title":"Eur J Biochem"},{"key":"861_CR19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-006-0327-1","volume":"185","author":"GL Gessa","year":"2006","unstructured":"Gessa GL, Orru A, Lai P, Maccioni P, Lecca R, Lobina C, Carai MA, Colombo G (2006) Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. Psychopharmacology (Berl) 185:248\u2013254","journal-title":"Psychopharmacology (Berl)"},{"key":"861_CR20","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","volume":"22","author":"R Gomez","year":"2002","unstructured":"Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca F (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612\u20139617","journal-title":"J Neurosci"},{"key":"861_CR21","first-page":"14","volume":"25","author":"F Grotenhermen","year":"2004","unstructured":"Grotenhermen F (2004) Pharmacology of cannabinoids. Neuro Endocrinol Lett 25:14\u201323","journal-title":"Neuro Endocrinol Lett"},{"key":"861_CR22","doi-asserted-by":"crossref","first-page":"23731","DOI":"10.1074\/jbc.M212369200","volume":"278","author":"S Hilairet","year":"2003","unstructured":"Hilairet S, Bouaboula M, Carriere D, Le Fur G, Casellas P (2003) Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 278:23731\u201323737","journal-title":"J Biol Chem"},{"key":"861_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.pa.35.040195.003135","volume":"35","author":"AC Howlett","year":"1995","unstructured":"Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607\u2013634","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"861_CR24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jat\/25.7.531","volume":"25","author":"W Huang","year":"2001","unstructured":"Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF (2001) Simultaneous determination of delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol inhuman plasma by solid phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. J Anal Toxicol 25:531\u2013537","journal-title":"J Anal Toxicol"},{"key":"861_CR25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","volume":"16","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Henningfield JE, Cone EJ (1992a) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276\u2013282","journal-title":"J Anal Toxicol"},{"key":"861_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.1992.100","volume":"52","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ (1992b) Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther 52:31\u201341","journal-title":"Clin Pharmacol Ther"},{"key":"861_CR27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","volume":"58","author":"MA Huestis","year":"2001","unstructured":"Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58:322\u2013330","journal-title":"Arch Gen Psychiatry"},{"key":"861_CR28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","volume":"134","author":"N Jamshidi","year":"2001","unstructured":"Jamshidi N, Taylor DA (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:1151\u20131154","journal-title":"Br J Pharmacol"},{"key":"861_CR29","doi-asserted-by":"crossref","first-page":"R343","DOI":"10.1152\/ajpregu.00706.2002","volume":"284","author":"TC Kirkham","year":"2003","unstructured":"Kirkham TC (2003) Endogenous cannabinoids: a new target in the treatment of obesity. Am J Physiol Regul Integr Comp Physiol 284:R343\u2013R344","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"861_CR30","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/00001756-200409150-00028","volume":"15","author":"B Foll Le","year":"2004","unstructured":"Le Foll B, Goldberg SR (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15:2139\u20132143","journal-title":"Neuroreport"},{"key":"861_CR31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","volume":"312","author":"B Foll Le","year":"2005","unstructured":"Le Foll B, Goldberg SR (2005) Cannabinoid CB1 antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312:875\u2013883","journal-title":"J Pharmacol Exp Ther"},{"key":"861_CR32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564","journal-title":"Nature"},{"key":"861_CR33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00213-006-0500-6","volume":"188","author":"LR McMahon","year":"2006","unstructured":"McMahon LR (2006) Discriminative stimulus effects of the cannabinoid CB(1) antagonist SR 141716A in rhesus monkeys pretreated with Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 188:306\u2013314","journal-title":"Psychopharmacology (Berl)"},{"key":"861_CR34","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","volume":"87","author":"R Mechoulam","year":"1965","unstructured":"Mechoulam R, Gaoni Y (1965) A total synthesis of dl-delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273\u20133274","journal-title":"J Am Chem Soc"},{"key":"861_CR35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejphar.2004.08.022","volume":"501","author":"M Navarro","year":"2004","unstructured":"Navarro M, Carrera MR, Del Arco I, Trigo JM, Koob GF, Rodriguez de Fonseca F (2004) Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats. Eur J Pharmacol 501:235\u2013237","journal-title":"Eur J Pharmacol"},{"key":"861_CR36","first-page":"250","volume":"34","author":"A Ohlsson","year":"1981","unstructured":"Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1981) Plasma levels of delta-9-tetrahydrocannabinol after intravenous, oral and smoke administration. NIDA Res Monogr 34:250\u2013256","journal-title":"NIDA Res Monogr"},{"key":"861_CR37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bms.1200090103","volume":"9","author":"A Ohlsson","year":"1982","unstructured":"Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1982) Single dose kinetics of deuterium labelled delta-1-tetrahydrocannabinol in heavy and light cannabis users. Biomed Environ Mass Spectrom 9:6\u201310","journal-title":"Biomed Environ Mass Spectrom"},{"key":"861_CR38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"FX Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761\u2013775","journal-title":"JAMA"},{"key":"861_CR39","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1189\/jlb.1203638","volume":"75","author":"GK Rao","year":"2004","unstructured":"Rao GK, Zhang W, Kaminski NE (2004) Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells. J Leukoc Biol 75:884\u2013892","journal-title":"J Leukoc Biol"},{"key":"861_CR40","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00545.2002","volume":"284","author":"C Ravinet Trillou","year":"2003","unstructured":"Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, Soubrie P (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284:R345\u2013R353","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"861_CR41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","volume":"28","author":"C Ravinet Trillou","year":"2004","unstructured":"Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes 28:640\u2013648","journal-title":"Int J Obes"},{"key":"861_CR42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"MR Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona MR, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere JC, Le Fur GL (1994) SR141716, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240\u2013244","journal-title":"FEBS Lett"},{"key":"861_CR43","first-page":"179","volume":"9","author":"J Simiand","year":"1998","unstructured":"Simiand J, Keane M, Keane PE, Soubrie P (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179\u2013181","journal-title":"Behav Pharmacol"},{"key":"861_CR44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jnr.10242","volume":"68","author":"MC Tomasini","year":"2002","unstructured":"Tomasini MC, Ferraro L, Bebe BW, Tanganelli S, Cassano T, Cuomo V, Antonelli T (2002) Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors. J Neurosci Res 68:449\u2013453","journal-title":"J Neurosci Res"},{"key":"861_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00213-003-1620-x","volume":"172","author":"AH Tseng","year":"2004","unstructured":"Tseng AH, Craft RM (2004) CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats. Psychopharmacology (Berlin) 172:25\u201330","journal-title":"Psychopharmacology (Berlin)"},{"key":"861_CR46","doi-asserted-by":"crossref","first-page":"P50","DOI":"10.1016\/j.clpt.2005.12.177","volume":"79","author":"S Turpault","year":"2006","unstructured":"Turpault S, Kanamaluru V, Lockwood GF, Bonnet D, Newton J (2006) Rimonabant pharmacokinetics in healthy and obese subjects. Clin Pharmacol Ther 79:P50","journal-title":"Clin Pharmacol Ther"},{"key":"861_CR47","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"LF Gaal Van","year":"2005","unstructured":"Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1389\u20131397","journal-title":"Lancet"},{"key":"861_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0163-7258(02)00252-8","volume":"95","author":"JM Walker","year":"2002","unstructured":"Walker JM, Huang SM (2002) Cannabinoid analgesia. Pharmacol Ther 95:127\u2013135","journal-title":"Pharmacol Ther"},{"key":"861_CR49","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","volume":"100","author":"L Wang","year":"2003","unstructured":"Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 100:1393\u20131398","journal-title":"Proc Natl Acad Sci USA"},{"key":"861_CR50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","volume":"63","author":"TM Westlake","year":"1994","unstructured":"Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer\u2019s brains. Neuroscience 63:637\u2013652","journal-title":"Neuroscience"},{"key":"861_CR51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","volume":"143","author":"CM Williams","year":"1999","unstructured":"Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid (BC1) receptors. Psychopharmacology 143:315\u2013317","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-007-0861-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0861-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:38Z","timestamp":1558629098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-007-0861-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0861-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,10]]}}}